Translational Development Acquisition Corp. (TDAC) Stock Analysis

Price updated 5 days ago · SEC data refreshed 3 months ago · Not investment advice

Translational Development Acquisition Corp.

TDAC Financial Services SPACs📄 SEC filings ↗
Valuation N/A
▾ What's in the 32/100 risk score? (higher = riskier)
Fundamental health (43%) 20/100 → +8.6
leverage 20/100
Smart money (short interest + insider buying) (31%) 48/100 → +15.1
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (26%) 33/100 → +8.5
Total32/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). See the Financial Health section for the full balance-sheet read.

💵 Price $10.86 · 5 days ago 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read TDAC

We are not publishing an intrinsic value for this one — the section below says exactly why. Everything on this page that comes straight from the filings and the tape is still here; treat the missing valuation as a known gap, not as a verdict on the business.

Where to start — the sections that matter most for this stock
  1. 1 Reported earnings & margins ↓
    What the company actually reported — unaffected by the valuation being held.
  2. 2 Balance sheet & book value ↓
    Assets, liabilities and equity as filed.
  3. 3 Who's selling & betting against it ↓
    Insider and short-interest behaviour needs no valuation model.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ A share-count quirk blocked the per-share math

The share count we read for TDAC looks wrong — common for multi-class / founder-controlled filers that report shares per share-class. That makes per-share figures (including intrinsic value) misleading, so we suppressed them. The company's total financials below are sound.

What to use instead: Lean on the totals — revenue, net income, cash flow — and the balance sheet. Multi-class share counts are being corrected; once fixed, the per-share valuation returns automatically.

This note is only about the single DCF fair-value number — TDAC's full financial statements, health scores, and written analysis are all below.

Loading insider & short-seller data…
Checking filings for failure warnings…

How to read a company this small

This is a SPAC (Special Purpose Acquisition Company) or blank-check entity. There's no operating business yet — it's a pool of cash looking for a target to merge with.

✅ What actually drives value for this kind of company
  • Cash in trust per share — typically $10.00 at IPO, slowly accrues interest
  • Sponsor reputation and track record
  • Time remaining to find a target (usually 18-24 months)
  • Announced target (if any) and the proposed deal structure
  • Warrant terms — usually 1/2 to 1/4 warrant per share at $11.50 strike
❌ Metrics that DON'T apply (ignore these even if you see them below)

All operating metrics — there are no operations. Revenue, FCF, EBITDA are all near zero or sponsor expenses.

📚 Where to actually look

SEC filings for the S-1 prospectus. Recent 8-K filings for target announcements. SPACInsider for sponsor track records.

Classified as SPAC / Blank-Check Company (confidence 95%). Disagree? An admin can override via the post edit screen.

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
Not available for this filer

The Z-score needs working capital, retained earnings, EBIT, sales and total assets from the latest balance sheet, and at least one of those isn't reported in machine-readable form here — common for foreign private issuers. We leave it blank rather than compute a distress verdict from an estimated input. It doesn't affect the reported figures in the financial tables below.

Piotroski-style checks (partial — not a standard F-score)
3 passed · 3 failed · 3 n/a
Partial result, not a standard F-score: 3 of 6 measurable checks passed. 3 of the 9 standard checks couldn't be measured, so this is scored out of 6, not 9 — it isn't comparable to a published F-score.
▾ The checks — what passed, what didn't (and what we couldn't measure)
  • Positive net income
    Net income $6.4M in FY2025.
  • Positive operating cash flow
    Operating cash flow -$0.6M (was -$0.9M the prior year).
    Why this matters: Profit can be an accounting figure; cash from running the business is harder to fake. Negative operating cash flow means the core business consumes cash and must be funded externally.
  • Cash flow backs up reported profit
    Operating cash flow -$0.6M vs net income $6.4M.
    Why this matters: When cash generated exceeds reported earnings, profits are high-quality (not propped up by accruals or one-time items).
  • Return on assets improving
    Return on assets 3.5% vs 0.0% a year ago.
  • Debt load (vs assets)
    The filing reports no interest-bearing debt in either year (total assets $181.7M).
  • Short-term liquidity (current ratio)
    Current ratio 0.07x vs 3.09x a year ago — below 1.0, a caution flag.
    Why this matters: The current ratio compares assets it can turn to cash within a year against bills due within a year. Below 1.0 means it may struggle to cover near-term obligations.
  • · Share count (dilution) (n/a — data not reported; not scored)
  • · Pricing power (gross margin) (n/a — data not reported; not scored)
  • · Sales per asset (asset turnover) (n/a — data not reported; not scored)

Missing data is never counted as a pass or a fail — it's shown as n/a and excluded from the denominator. Each check compares the company against its own prior year.

Price$10.86
Model IVNot applicable — DCF couldn't price this stock. The other valuation lenses on this page (reverse-DCF, peers, sector lens — whichever apply to this filer) carry the read instead.

A standard discounted cash flow?DCF — Discounted Cash Flow — sums up all future cash a business will produce, adjusted for the fact that future dollars are worth less than dollars today.
Why it matters: It is the most fundamentally honest valuation method when applicable — but only works for companies with predictable, positive cash flow.
Reference: Best for: mature, profitable businesses. Fails for: pre-profit growth, banks, REITs.
Full explanation →
(DCF) valuation is not meaningful for Translational Development Acquisition Corp. (TDAC) because its operating cash flow is negative, indicating it is currently burning cash. Investors are likely betting on the success of a future business combination, as TDAC is a Special Purpose Acquisition Company (SPAC). To value it, one would need a clear target acquisition with projected future cash flows. The primary quantifiable risk is the extremely low current ratio of 0.07, suggesting significant liquidity issues if a deal doesn't materialize or if current liabilities are not managed.

⚠️ FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.

As of 3 months ago

Anatomy of a share

What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

Per-share economics aren't reliable for this filer. Its income statement or share count isn't fully reported to SEC EDGAR (common for foreign private issuers and thinly-disclosed OTC names), so we don't break it down per share here — the figures would be misleading. See the financial tables below for what is reported.

What you actually need to decide

Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

🐂 The Bull Case
The most important thing that must go right is the successful identification and completion of a high-quality business combination, which would transform its negative operating cash flow into a profitable enterprise.
🐻 The Bear Case
The biggest fundamental risk is the failure to complete a suitable business combination within the mandated timeframe, which would lead to liquidation and return of capital, exacerbated by the current ratio of 0.07 indicating poor liquidity.
📌 Signposts to watch — update your view as these print
  • Announcement of a definitive agreement for a business combination
  • Shareholder vote on a proposed merger
  • Extension of the deadline for completing an acquisition

The trend, in plain numbers (FY2024 → FY2025, latest reported)

Straight from the financial statements — no model, no opinion. For a small or unprofitable company, the direction of these numbers usually tells you more than any single valuation.

✅ Improving
  • Free cash flow is negative at -$608K — the cash burn narrowed vs last year.
  • Swung to a profit of $6.4M (from a loss the prior year).

Nothing was clearly worsening year-over-year.

Management & Leadership

Translational Development Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As a SPAC, it does not have ongoing operations or a traditional CEO in the operational sense prior to an acquisition. The leadership typically consists of a Chairman and CEO focused on identifying and executing a merger target.

Omar Ishrak
Chairman and CEO
Randal J. Kirk
President and Director

What They Make

TDAC is a Special Purpose Acquisition Company (SPAC) that raises capital through an IPO to acquire an existing private company, effectively taking it public. Its 'customers' are the investors who buy its shares, hoping for a successful merger.

End Markets

Private company acquisitionPublic market accessInvestment vehicles

Revenue Drivers

Successful business combination
Investor confidence in management team
Market sentiment for SPACs
Beta: 0.55

Why Is It Priced Like This?

Why Customers Pay

Provides an alternative path to public markets for private companies
Offers investors exposure to growth companies pre-IPO
Experienced management team to identify acquisition targets
No discounted-cash-flow value for this filer This company's reported free cash flow is negative, so a discounted-cash-flow valuation has no positive cash stream to discount. That is a fact about the business, not missing data — the reported figures below are complete.

What we use instead: earnings (P/E, EV/EBIT), book value (P/B) — computed from the figures this company does report, shown in the sections below. Those numbers are unaffected by the missing cash-flow data.

The market prices TDAC based on expectations of a future successful business combination rather than current cash flows, as its operating cash flow is negative. The market may be assigning value to the potential for a high-growth target acquisition, which is not in the model. The positive net income in the latest period, despite negative operating cash flow, suggests some non-operating gains or specific accounting treatments for SPACs, but the low current ratio of 0.07 highlights significant liquidity risk.

Business Model & Valuation

How They Make Money

Raising capital through initial public offerings (IPO)
Identifying and acquiring a target private company
Facilitating the target company's public listing

As a SPAC, TDAC primarily funds itself through equity raises from its IPO, with proceeds held in trust for a future acquisition. There are no dividends or buybacks prior to a business combination.

Growth / Revenue DCF

Negative free cash flow: revenue/margin growth model used - standard FCF DCF is unreliable for companies still scaling.

Show advanced inputs
Revenue Growth15.0%

What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project net interest income and fee-income lines independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

Maturity & Competitive Position

Growth / re-investment phase

Moat Signals

Experienced management team in deal-making
Access to institutional capital
Reputation for successful past ventures

Net income was positive in the latest period, but operating cash flow has been negative for all three reported years.

Geography & Markets

Translational Development Acquisition Corp. is typically US-headquartered, focusing on identifying acquisition targets globally, though specific geographic segments are not available from current data sources.

Geographic Risks

Regulatory risk in SPAC mergers and acquisitions
Concentration risk on finding a single suitable target company

Market Signals

These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

Model neutral, tape bullish
RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation →
(14)
77.1OverboughtBought up hard recently — stretched; pullbacks are common from here.
MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →
BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
50-Day Average$10.63Price above (+2.2%)Price above its 50-day average = near-term uptrend.
200-Day Average$10.49Price aboveThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
50 vs 200 CrossGolden50-day above 200-dayA "golden cross" — the medium trend has overtaken the long trend (often read as bullish).

Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

Data Quality & Risk Flags (8 notes — click to expand/collapse)

Guardrail Notes (8)
  • FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.
  • INVARIANT: weighted IV is non-positive. Model may not be appropriate.
  • Model implies no positive equity value under these assumptions. Valuation is speculative/low-confidence.
  • Shares from unknown — per-share values may be less accurate.
  • Illiquidity discount 25% applied (small/micro-cap — harder to exit, demand a margin).
  • Shares/market cap missing or defaulted; per-share valuation unreliable.
  • Shares defaulted to 1; IV is NOT meaningful — treat as data-unavailable.
  • DATA UNAVAILABLE: per-share values suppressed due to missing/unreliable shares data.

Financial Statements (5-year tables — click to expand)

From Translational Development Acquisition Corp.'s SEC filings (EDGAR).

Income (5yr)

YearRevenueNet IncomeEPS
20256.4M
2024-71,012$0.00
2023-485,550$0.00

Cash Flow (5yr)

Capital expenditure isn't tagged in this filer's machine-readable data (the CapEx column shows "—"). The free-cash-flow column is therefore operating cash flow less stock-based compensation only — an upper bound on true owner earnings, not the real figure. Companies that report capex under a custom label (some large IFRS filers do) look better here than they are.

YearOperating CFCapEx− SBC & adj.Free Cash Flow
2025 -608,387 -608,387
2024 -851,446 -851,446
2023 -204 -204

How we define FCF: operating cash flow − capital expenditure − stock-based compensation (owner-earnings basis — SBC is a real cost to shareholders even though it's non-cash). This is the same owner-earnings FCF definition the valuation model uses, though the DCF's starting value is a projected from revenue × terminal margin, not this single year.

Balance Sheet

Total Assets181.7M
Total Liabilities6.6M
Equity-6.5M
PG
Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
🔔 Follow $TDAC — free insider alerts
One email when an insider buys $TDAC on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.